Paper

A network medicine approach to elucidate mechanisms underlying menopause-induced knee osteoarthritis

Jackson, Natalie, Gilmer, Gabrielle, Ambrosio, Fabrisia, Evans, Christopher, Hettinger, Zachary, Bean, Allison C, Iijima, Hirotaka, Bergmann, Juliana, Thurston, Rebecca C

2023

Overview

Post-menopausal women present with the highest incidence and morbidity of knee osteoarthritis (KOA), but no disease-modifying therapies are available. This treatment gap may be driven by the absence of menopause in preclinical studies, as rodents do not naturally maintain a menopausal phenotype. Here, we employed a chemically-induced menopause model to map the trajectory of KOA at the tissue and proteome levels and test therapeutics in silico. Middle-aged female mice were randomized to sesame oil (non-menopause) or 4-vinycyclohexene diepoxide (menopause) injections. Following comprehensive validation of our model, knees were collected across perimenopause and menopause for histology, and cartilage samples were micro-dissected for mass spectrometry proteomics. Menopause mice displayed aggravated cartilage degeneration and synovitis relative to non-menopause mice. An unbiased pathway analysis revealed progesterone as a predominant driver of pathological signaling cascades within the cartilage proteome. Network medicine-based analyses suggested that menopause induction amplifies chondrocyte senescence, actin cytoskeleton-based stress, and extracellular matrix disassembly. We then used in silico drug testing to evaluate how restoration of sex hormones impacted the cartilage network. The greatest restoration was observed with combined estradiol/progesterone treatment (i.e., hormone therapy), although in silico treatment with a senolytic drug also partially recovered the cartilage proteome. Taken together, our findings using a translatable female aging model demonstrate that menopausal aging induces progressive cartilage degeneration and amplifies age-related synovitis. These changes may be driven by a previously unappreciated role of progesterone loss and menopause-induced cellular senescence. Lastly, in silico treatment suggests an estradiol/progesterone cocktail or senolytics may attenuate menopause-induced cartilage pathology.Competing Interest StatementThe authors have declared no competing interest.

• Publisher: Cold Spring Harbor Laboratory Press,Cold Spring Harbor Laboratory
• Subject: 17β-Estradiol / Actin / Aging / Arthritis / Cartilage / Cartilage diseases / Chondrocytes / Cytoskeleton / Degeneration / Extracellular matrix / Knee / Mass spectroscopy / Menopause / Morbidity / Osteoarthritis / Pathology / Phenotypes / Post-menopause / Progesterone / Proteomes / Proteomics / Senescence / Sex hormones / Synovitis